Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 217

1.

CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.

Sone K, Oguri T, Nakao M, Kagawa Y, Kurowaka R, Furuta H, Fukuda S, Uemura T, Takakuwa O, Kanemitsu Y, Ohkubo H, Takemura M, Maeno K, Ito Y, Sato H, Muramatsu H, Niimi A.

Anticancer Res. 2017 Feb;37(2):935-939.

PMID:
28179355
2.

Histopathological Aspects Described in Patients with Hepatic Hydatidosis.

Mihăilă DE, Nitu MC, Potecă TD.

Rom J Intern Med. 2016 Jan-Mar;54(1):47-53.

PMID:
27141570
3.

Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.

Martín-Sánchez E, Pernaut-Leza E, Mendaza S, Cordoba A, Vicente-Garcia F, Monreal-Santesteban I, Vizcaino JP, De Cerio MJ, Perez-Janices N, Blanco-Luquin I, Escors D, Ulazia-Garmendia A, Guerrero-Setas D.

Virchows Arch. 2016 Jul;469(1):51-9. doi: 10.1007/s00428-016-1941-x. Epub 2016 Apr 21.

PMID:
27097811
4.

Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction.

Cai X, Feng L, Liu H, Xu M, Qu Y, Wan X, Gao C, Lu L.

Ann Hepatol. 2016 May-Jun;15(3):386-93. doi: 10.5604/16652681.1198813.

5.

Nanostructured zirconia decorated reduced graphene oxide based efficient biosensing platform for non-invasive oral cancer detection.

Kumar S, Sharma JG, Maji S, Malhotra BD.

Biosens Bioelectron. 2016 Apr 15;78:497-504. doi: 10.1016/j.bios.2015.11.084. Epub 2015 Nov 30.

PMID:
26657594
6.

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.

Hsu YP, Hsieh CH, Chien HT, Lai CH, Tsao CK, Liao CT, Kang CJ, Wang HM, Chang JT, Huang SF.

World J Surg Oncol. 2015 Aug 21;13:253. doi: 10.1186/s12957-015-0656-9.

7.

The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma.

Gong SC, Cho MY, Lee SW, Kim SH, Kim MY, Baik SK.

J Gastroenterol Hepatol. 2016 Jan;31(1):206-12. doi: 10.1111/jgh.13063.

PMID:
26212571
8.

Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.

Fatourou E, Koskinas J, Karandrea D, Palaiologou M, Syminelaki T, Karanikolas M, Felekouras E, Antoniou E, Manesis EK, Delladetsima J, Tiniakos D.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1094-102. doi: 10.1097/MEG.0000000000000398.

PMID:
26011233
9.

Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker.

Gao J, Lv F, Wang J, Wu Z, Li J, Yan C, Qi J.

Tumour Biol. 2015 Nov;36(11):8295-9. doi: 10.1007/s13277-015-3511-2. Epub 2015 May 23.

PMID:
26002573
10.

CK19 is a sensitive marker for yolk sac tumours of the testis.

Bremmer F, Ströbel P, Jarry H, Strecker J, Gaisa N, Strauß A, Schweyer S, Radzun HJ, Behnes CL.

Diagn Pathol. 2015 Mar 24;10:7. doi: 10.1186/s13000-015-0243-y.

11.

Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.

Kawai T, Yasuchika K, Ishii T, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Mizumoto M, Hatano E, Uemoto S.

Clin Cancer Res. 2015 Jul 1;21(13):3081-91. doi: 10.1158/1078-0432.CCR-14-1936. Epub 2015 Mar 27.

12.

Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.

Huang L, Chen W, Liang P, Hu W, Zhang K, Shen S, Chen J, Zhang Z, Chen B, Han Y, Meng F, DeMorrow S, Yin X, Lai J, Liang L.

Dig Dis Sci. 2015 May;60(5):1273-83. doi: 10.1007/s10620-014-3472-0. Epub 2014 Dec 9.

PMID:
25487191
13.

Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases.

Masai K, Nakagawa K, Yoshida A, Sakurai H, Watanabe S, Asamura H, Tsuta K.

Lung Cancer. 2014 Dec;86(3):318-23. doi: 10.1016/j.lungcan.2014.09.018. Epub 2014 Oct 12.

PMID:
25453845
14.

Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes.

Ju JH, Oh S, Lee KM, Yang W, Nam KS, Moon HG, Noh DY, Kim CG, Park G, Park JB, Lee T, Arteaga CL, Shin I.

Cell Death Differ. 2015 Apr;22(4):665-76. doi: 10.1038/cdd.2014.155. Epub 2014 Oct 24.

15.

Diagnostic accuracy of urinary cytokeratin 19 fragment for endometriosis.

Lessey BA, Savaris RF, Ali S, Brophy S, Tomazic-Allen S, Chwalisz K.

Reprod Sci. 2015 May;22(5):551-5. doi: 10.1177/1933719114553064. Epub 2014 Oct 8.

16.

Keratin 19 expression correlates with poor prognosis in breast cancer.

Kabir NN, Rönnstrand L, Kazi JU.

Mol Biol Rep. 2014 Dec;41(12):7729-35. doi: 10.1007/s11033-014-3684-6. Epub 2014 Aug 26.

PMID:
25156534
17.
18.
19.

Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis--a prospective study.

Kuessel L, Jaeger-Lansky A, Pateisky P, Rossberg N, Schulz A, Schmitz AA, Staudigl C, Wenzl R.

Gynecol Endocrinol. 2014 Jan;30(1):38-41. doi: 10.3109/09513590.2013.856409. Epub 2013 Nov 12.

PMID:
24219598
20.

CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients.

Shi WL, Li J, Du YJ, Zhu WF, Wu Y, Hu YM, Chen YC.

Med Oncol. 2013 Dec;30(4):755. doi: 10.1007/s12032-013-0755-9. Epub 2013 Nov 1.

PMID:
24178178

Supplemental Content

Support Center